Kalon Biotherapeutics

Read more
Andrew Strong's photo - President & CEO of Kalon Biotherapeutics

President & CEO

Andrew Strong

CEO Approval Rating

70/100

Est. Annual Revenue
$7.5M
Agree?
Est. Employees
121
Agree?
Sector

Update Industry

Kalon Biotherapeutics Acquisitions

No recent acquisitions found related to Kalon Biotherapeutics

Kalon Biotherapeutics Funding History

No recent funding data found related to Kalon Biotherapeutics

Kalon Biotherapeutics Investments

No recent investments found related to Kalon Biotherapeutics

Kalon Biotherapeutics News

December 23, 2014XCONOMY

Officials Say Fuji's Purchase of Kalon Boosts Texas's Biotech Profile

A Texas A&M University spinoff has been acquired by Fujifilm Diosynth Biotechnologies, a transaction ... See more »
December 22, 2014FIERCE PHARMA MANUFACTURING

Fujifilm becomes part of U.S. pandemic defense with deal for Kalon Biotherapeutics

Japan's Fujifilm has completed the purchase of not quite 50% of vaccine specialist Kalon Biotherapeut... See more »
December 21, 2014CONTRACT PHARMA

FUJIFILM Completes Kalon Acquisition

Expands biopharma CMO business... See more »
December 17, 2014HOUSTON BUSINESS JOURNAL

College Station biotech company bought by major international player

Kalon Biotherapeutics LLC, a College Station-based biotech manufacturer that specializes in vaccines,... See more »
October 27, 2014GENETIC ENGINEERING & BIOTECHNOLOGY NEWS

Fujifilm Acquires Kalon Biotherapeutics

CMO Fujifilm Diosynth Biotechnologies (FDBU) inked a deal to acquire Kalon Biotherapeutics, another C... See more »
October 27, 2014CLINICASPACE

FUJIFILM Buys 49 Percent Of U.S. Vaccine Maker As Ebola Spreads

Japan's Fujifilm Holdings Corp said on Monday it would buy 49 percent of Texas-based Kalon Biotherape... See more »

Kalon Biotherapeutics Press Releases

June 4, 2014PRWEB

Medicenna Therapeutics Selects Kalon as Contract Manufacturer for New Cancer Drug

First commercial project focuses on manufacturing of novel therapeutic for children with brain cancer... See more »

Social Media

Kalon Biotherapeutics Headquarters

100 Discovery Dr Suite 200

College Station, Texas77845

979-458-2300

Driving Directions »

Trending Companies

Kalon Biotherapeutics Summary

ABOUT

Overview

Kalon Biotherapeutics engages in drug development services. Kalon Biotherapeutics was founded in 06/2011. Kalon Biotherapeutics' headquarters is located in College Station, Texas, USA 77845. Kalon Biotherapeutics' President & CEO, Andrew Strong, curr...

CEO

Kalon Biotherapeutics's President & CEO, Andrew Strong, currently has an approval rating of 70%. Kalon Biotherapeutics's primary competitors are

Frequently Asked Questions about Kalon Biotherapeutics

  1. When was Kalon Biotherapeutics founded?

    Kalon Biotherapeutics was founded in 06/2011
  2. Who is Kalon Biotherapeutics's CEO?

    Kalon Biotherapeutics's CEO is Andrew Strong
  3. How much revenue does Kalon Biotherapeutics generate?

    Kalon Biotherapeutics generates $7.5M in revenue
  1. How much funding does Kalon Biotherapeutics have?

    Kalon Biotherapeutics has historically raised $0 in funding
  2. Where is Kalon Biotherapeutics's headquarters?

    Kalon Biotherapeutics's headquarters is in College Station Texas, USA
  3. How many employees does Kalon Biotherapeutics have?

    Kalon Biotherapeutics has 121 employees